Items stated in the management plan
WithdrawnThe full-year consolidated earnings forecast for the fiscal year ending May 2026 was revised downward because customer traffic fell below expectations due to intensifying competition in the drugstore industry and weaker-than-expected inbound demand, among other factors, and initiatives to improve the gross profit margin did not produce the expected results. In addition, company-wide reforms, including a review of the earnings structure, securing specialized personnel, and investment in DX and systems, became necessary. As the underlying conditions therefore differed substantially from those at the time the medium-term management plan was formulated, its achievability through the final year became uncertain.
| Item | Details |
|---|---|
| Plan name | Medium-Term Management Plan |
| Plan period | From the fiscal year ending May 2026 through the fiscal year ending May 2028 |
| Progress against the plan | Withdrawn |
| Sales Target | Not disclosed → Withdrawn |
| Operating profit target | Not disclosed → Withdrawn |
| Operating profit margin target | Not disclosed → Withdrawn |
| Net income target | Not disclosed → Withdrawn |
| ROE target | ROE above 10% → Withdrawn |
| ROIC target | Not disclosed → Withdrawn |
| Key initiatives | Review of the earnings structure, Securing Specialized Talent, Investment in DX and systems |
| Results under the previous plan | ROE above 10% → Not disclosed |
| Reason for revision or withdrawal | The full-year consolidated earnings forecast for the fiscal year ending May 2026 was revised downward because customer traffic fell below expectations due to intensifying competition in the drugstore industry and weaker-than-expected inbound demand, among other factors, and initiatives to improve the gross profit margin did not produce the expected results. In addition, company-wide reforms, including a review of the earnings structure, securing specialized personnel, and investment in DX and systems, became necessary. As the underlying conditions therefore differed substantially from those at the time the medium-term management plan was formulated, its achievability through the final year became uncertain. |
| Risks identified | Intensifying competition in the drugstore industry, Weaker-than-expected inbound demand, Customer traffic falling below expectations, Initiatives to improve the gross profit margin failing to produce the expected results, Divergence from the underlying assumptions at the time the medium-term management plan was formulated, Increasing uncertainty regarding the achievability of the medium-term management plan through its final year |
| Date of board resolution | 19 June 2026 |
| Publication date | 19 June 2026 |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The full-year consolidated earnings forecast for the fiscal year ending May 2026 was revised downward because customer traffic fell below expectations due to intensifying competition in the drugstore industry and weaker-than-expected inbound demand, among other factors, and initiatives to improve the gross profit margin did not produce the expected results. In addition, company-wide reforms, including a review of the earnings structure, securing specialized personnel, and investment in DX and systems, became necessary, causing the underlying assumptions to differ substantially from those at the time the plan was formulated and making the plan's achievability in its final year uncertain.